CIK 0001590750 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2023 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|
| Revenue (USD) | ||||
| Net income (USD) | -110.7 M | -41.9 M | -32.7 M | |
| Diluted EPS (USD/shares) | -5.31 | -31.13 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-20 | 4 | 4 | 2026-08-19 |
| 2026-08-20 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-19 | 144 | 144 | |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-06-29 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-06-26 |
| 2026-06-26 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-03 | 8-K | 8-K items 5.07 | 2026-06-02 |
| 2026-05-28 | 8-K | 8-K items 1.02 | 2026-05-27 |
| 2026-05-26 | 8-K | 8-K items 1.01 | 2026-05-24 |
| 2026-05-15 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-13 | 4 | OWNERSHIP DOCUMENT | 2026-05-11 |
| 2026-05-13 | SCHEDULE 13D/A | SCHEDULE 13D/A |
Forms on file (last 1,000): 4 207, 8-K 173, 3 48, SC 13G/A 48, 10-Q 37, SC 13G 37, 424B5 24, CORRESP 18. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VRDN (0.002 USD), /gw/filings/filings?ticker=VRDN&form=8-K, /gw/filings/facts?ticker=VRDN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange